Session I: NHMP and Its Use/Non-Use
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 181
Monitoring Human Tissues for Toxic Substances Appendix A Workshop Agenda January 24–25, 1989 Tuesday, January 24th (NAS Bldg., Lecture Room 125) 8:00 a.m. Continental breakfast 8:30 Welcome and opening remarks Session I: NHMP and Its Use/Non-Use 8:45 EPA Overview of NHMP: J.Breen, Office of Toxic Substances, US EPA, Washington, DC 9:15 A User’s Perspective: H.Kang, Director, Virginia Office of Environmental Epidemiology, Washington, DC 9:30 A Non-User’s Perspective: L.Goldman, Chief, Environmental Epidemiology and Toxicology Section, DHS, Berkeley, CA 9:45 A General View on Monitoring Programs— “Toxic Chemicals: Predictive Monitoring and the Nature of Real Systems” R.Lewis, University des Saarlandes, Saarbruecken, West Germany 10:30 Break 10:45 General Discussion
OCR for page 182
Monitoring Human Tissues for Toxic Substances Session II: Monitoring Objectives 11:15 Panel Discussion: “Present and Future Monitoring Objectives-A National Perspective” V.Houk, CDC, Atlanta, GA; B. Johnson, ATSDR, Atlanta, GA; G.Lucier, NIEHS, RTP, NC; F.Young, FDA, Rockville, MD 12:15 p.m. Lunch Monitoring Objectives and Specialized Program Needs: 1:15 R.Kimbrough, Director, Risk and Health Capabilities, US EPA, Washington, DC 1:30 S.Sieber, Division Cancer Etiology, National Cancer Institute, Bethesda, MD 1:45 K.Sexton, Director, Office of Health Research, US EPA, Washington, DC 2:00 D.Stevenson, Consultant, Shell Oil Company, Houston, TX 2:15 Commentator and Formal Discussant: J.Gannon, US Fish and Wildlife Service, Ann Arbor, MI 3:15 Break 3:30 Public Session 4:30 Recess
OCR for page 183
Monitoring Human Tissues for Toxic Substances Wednesday, January 25th 8:00 a.m. Continental breakfast 8:30 Welcome and opening remarks Session III: Program Design 8:45 Collection: R.Aamodt, Program Director for Cytology/Pathology, NCI, Bethesda, MD Storage: 9:00 P.Mazur, Corporate Fellow, ORNL, Oak Ridge, TN 9:15 R.Hay, Head, Cell Culture Department, American Type Culture Collection, Rockville, MD 9:30 Archiving: S.Wise, Research Chemist, National Institute of Standards and Technology, Gaithersburg, MD 9:45 Data Management: R.Hay, Head, Cell Culture Department, American Type Culture Collection, Rockville, MD 10:00 Break Session IV: Alternative Monitoring Programs 10:15 US Fish and Wildlife Service-Great Lakes/Canadian Monitoring: J.Gannon, US FWS, Ann Arbor, MI 10:30 National Cancer Institute: S.Sieber, NCI, Bethesda, MD 10:45 National Health and Examination Survey (NHANES): R.Murphy, Director, Division of Health Examination Statistics, Hyattsville, MD 11:00 Market Basket (Total Diet) Survey: P.Lombardo, US FDA, Washington, DC
OCR for page 184
Monitoring Human Tissues for Toxic Substances 11:15 Total Exposure Assessment Methodology (TEAM) Study: L. Wallace, Environmental Scientist, US EPA, Washington, DC 11:30 Mussel Watch; National Status and Trends Program: G.Lauenstein, NOAA, Rockville, MD 11:45 Environmental Specimen Banking Program: S.Wise, Research Chemist, NIST, Gaithersburg, MD 12:00 General Discussion 12:30 Lunch Session V: Committee Panel Discussion 1:30 Workshop Discussion: Committee on National Monitoring of Human Tissues 2:30 Summary Remarks: J.Bailar, Committee Chair 2:45 Adjournment
Representative terms from entire chapter: